Rui Kang
- Molecular Biology top 0.05%
- Pulmonary and Respiratory Medicine top 0.01%
- Cancer Research top 0.01%
- Immunology top 0.1%
- Epidemiology top 0.2%
- Co-authors
- Daolin TangGuido KroemerXin ChenMichael T. LotzeHerbert J. ZehDaniel J. KlionskyJiao LiuYangchun Xie
- Topics
- Ferroptosis and cancer prognosis (105 papers)Advanced Glycation End Products research (57 papers)RNA modifications and cancer (56 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryNature Communications
- Partner nations
- United StatesChinaFrance
In The Last Decade
Rui Kang
265 papers receiving 46.2k citations
Hit Papers
Peers
Comparison fields: 5 of 178
- Molecular Biology 27.6k
- Pulmonary and Respiratory Medicine 23.4k
- Cancer Research 17.5k
- Immunology 7.2k
- Epidemiology 5.6k
Countries citing papers authored by Rui Kang
This map shows the geographic impact of Rui Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Kang more than expected).
Fields of papers citing papers by Rui Kang
This network shows the impact of papers produced by Rui Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Kang. The network helps show where Rui Kang may publish in the future.
Co-authorship network of co-authors of Rui Kang
This figure shows the co-authorship network connecting the top 25 collaborators of Rui Kang. A scholar is included among the top collaborators of Rui Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Kang. Rui Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 24 | |
| 3 | 1 | |
| 4 | 12 | |
| 5 | 36 | |
| 6 | 10 | |
| 7 | Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancerbreakdown → | 171 |
| 8 | 19 | |
| 9 | 8 | |
| 10 | 26 | |
| 11 | 47 | |
| 12 | 84 | |
| 13 | 116 | |
| 14 | HSPA5 Regulates Ferroptotic Cell Death in Cancer Cellsbreakdown → | 447 |
| 15 | 40 | |
| 16 | Activation of the p62‐Keap1‐NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cellsbreakdown → | 1566 |
| 17 | 2 | |
| 18 | 1 | |
| 19 | Analysis of storage stability of accelerometers | 1 |
| 20 | 220 |
About Rui Kang
Rui Kang is a scholar working on Clinical Biochemistry, Cancer Research and Pulmonary and Respiratory Medicine, having authored 280 papers that have together received 46.5k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (105 papers), Advanced Glycation End Products research (57 papers) and RNA modifications and cancer (56 papers). The work is most often cited by research in Cancer Research (17.5k citations), Pulmonary and Respiratory Medicine (23.4k citations) and Clinical Biochemistry (4.0k citations). Rui Kang has collaborated with scholars based in United States, China and France. Frequent co-authors include Daolin Tang, Guido Kroemer, Xin Chen, Michael T. Lotze, Herbert J. Zeh, Daniel J. Klionsky, Jiao Liu, Yangchun Xie, Xinxin Song and Xiaofang Sun. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.